Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of Results

16th Aug 2017 07:00

RNS Number : 0885O
Cathay International Holdings Ld
16 August 2017
 

 

 

Cathay International Holdings Limited

("Cathay" or the "Company")

 

Notice of Interim Results 2017

 

Hong Kong, 16 August 2017 - Cathay International Holdings Ltd. (LSE: CTI.L), an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"), today announces that the Company will issue its Interim Results for the six months ended 30 June 2017 on Wednesday 30 August 2017.

 

-ENDS-

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director) Tel: +852 2828 9289

Patrick Sung (Director and Controller)

 

N+1 Singer

Aubrey Powell/ Lauren Kettle - Corporate Finance Tel: +44 (0) 20 7496 3000

Brough Ransom - Sales

 

Consilium Strategic Communications

Mary-Jane Elliott/ Matthew Neal / Lindsey Neville Tel: +44 (0) 203 709 5700

 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and an operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on growth opportunities in the strong and growing domestic demand for high quality healthcare products in the PRC and build its portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a strong track record of identifying high- growth potential investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

 

The Group employs approximately 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORLLFIRTRIELID

Related Shares:

CTI.L
FTSE 100 Latest
Value8,275.66
Change0.00